Physician profile
Barry C Tedder
NPI 1467457358
$130,009.12
in general payments reported to CMS, 2019-2025
43 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $17K · 2021: $25K · 2022: $28K · 2023: $12K · 2024: $2,513 · 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,768 · Food and Beverage: $4,595 · Consulting Fee: $1,188 · Travel and Lodging: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,767.50 |
| Food and Beverage | $4,594.92 |
| Consulting Fee | $1,187.50 |
| Travel and Lodging | $521.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $84,593.54 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22,899.68 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $6,815.03 | 2021-2025 | Jardiance, Zepbound, Mounjaro |
| Avinger INC. | $3,616.65 | 2019-2023 | Pantheris |
| Bard Peripheral Vascular, INC. | $3,059.00 | 2019 | |
| Penumbra, INC. | $2,703.36 | 2022-2023 | Penumbra System, Smart Coil, Indigo System |
| Novartis Pharmaceuticals Corporation | $1,847.72 | 2019-2025 | |
| Boston Scientific Corporation | $1,435.53 | 2019-2025 | Eluvia, Rotapro, Avvigo Guidance System |
| Abbott Laboratories | $638.80 | 2019-2025 | Freestyle Libre 3, Jeti Peripheral Catheter, Aveir |
| Astrazeneca Pharmaceuticals LP | $388.87 | 2019-2025 | Farxiga, Airsupra, Wainua |
| Abiomed | $353.43 | 2019-2025 | Impella |
| Livanova USA, INC. | $185.11 | 2023 | Lifesparc |
| Avantec Vascular Corporation | $134.68 | 2023 | |
| Novo Nordisk INC | $125.97 | 2025 | Wegovy |
| Medtronic, INC. | $111.66 | 2022-2025 | Pulseselect |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $111.52 | 2019-2025 | Evkeeza |
| Esperion Therapeutics, INC. | $109.18 | 2021 | |
| W. L. Gore & Associates, INC. | $96.61 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Kaneka Medical America LLC | $95.00 | 2020 | |
| Opsens INC. | $89.33 | 2019 | |
| Cvrx, INC. | $66.34 | 2023-2024 | Barostim Neo System |
| Terumo Medical Corporation | $60.80 | 2022-2025 | R2p Misago, Azur Cx Detachable, Metacross Otw |
| Pfizer INC. | $58.11 | 2019-2025 | |
| Dexcom, INC. | $45.38 | 2025 | Dexcom G6 Transmitter |
| Biotronik INC. | $42.56 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $40.98 | 2019 | |
| Edwards Lifesciences Corporation | $36.54 | 2020-2025 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.58 | 2020-2023 | Lifevest |
| Lundbeck LLC | $32.35 | 2025 | Rexulti |
| Shockwave Medical, INC | $30.01 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Corindus INC. | $26.25 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.73 | 2019-2023 | |
| Abbvie INC. | $24.22 | 2025 | |
| Bracco Diagnostics INC. | $19.62 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.61 | 2025 | |
| Janssen Pharmaceuticals, INC | $14.67 | 2022 | |
| Cordis US Corp. | $13.30 | 2023 | Selution Slrpta |
| Gilead Sciences, INC. | $11.40 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$15,517.66 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Tedder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.